Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Glitaray-M 0.5 Tablet PR

Prescription Icon
Prescription Required

Marketer

Lloyd Healthcare Pvt Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glitaray-M 0.5 Tablet PR

Diabexe Duo 0.5mg tablets are anti-diabetic medications combining two active ingredients for adult type 2 diabetes management. This formulation helps regulate blood glucose. Administer Diabexe Duo with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, increasing risks like kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Recognize these signs and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption raises hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections; weight gain may occur. Do not use Diabexe Duo if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your physician of any heart conditions before starting treatment. Pregnant or lactating individuals should consult their doctor prior to use. Regular blood sugar monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glitaray-M 0.5 Tablet PR

No text provided. Please provide the text you wish me to rephrase.

Uses of Glitaray-M 0.5 Tablet PR

Managing type 2 diabetes

Major Benefits of Glitaray-M 0.5 Tablet PR:

Follow your doctor's instructions or consult the product label for guidance. Ingest Glitaray-M 0.5 Tablet PR with a meal.

Common Side effects of Glitaray-M 0.5 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glitaray-M 0.5 Tablet PR:

Follow your physician's instructions or refer to the product label for usage guidelines. Administer Glitaray-M 0.5 Tablet PR with a meal.

How Glitaray-M 0.5 Tablet PR works:

Glitaray-M 0.5 PR tablets contain Glimepiride and Metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to produce more insulin, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing liver glucose output, slowing intestinal glucose absorption, and enhancing insulin responsiveness in tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glitaray-M 0.5 Tablet PR and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glitaray-M 0.5 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Using Glitaray-M 0.5 Tablet PR while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates the drug poses a risk to the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glitaray-M 0.5 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glitaray-M 0.5 Tablet PR. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glitaray-M 0.5 Tablet PR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation with a low dose of Glitaray-M 0.5 Tablet PR is typical; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glitaray-M 0.5 Tablet PR :

Should you forget a dose of Glitaray-M 0.5 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glitaray-M 0.5 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Glitaray-M 0.5 Tablet PR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glitaray-M 0.5 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glitaray-M 0.5 Tablet PR and seek immediate medical attention.
Glitaray-M 0.5 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glitaray-M 0.5 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glitaray-M 0.5 Tablet PR can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glitaray-M 0.5 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glitaray-M 0.5 Tablet PR with alcohol is unsafe. This combination can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glitaray-M 0.5 Tablet PR
92
MRP 106
13% off